A 23-person clinical trial conducted at Laval University in Quebec, Canada, has confirmed that brown seaweed (InSea2, innoVactiv, Inc., based in Quebec, Canada) positively affects glucose and insulin levels after eating. 

Study participants consumed two capsules of seaweed extract (total 500 mg) 30 minutes before eating bread containing 50 grams of carbohydrates. Glucose and insulin levels were measured for three hours after eating. One week later, the test was repeated with a placebo.

Overall, the seaweed extract was linked with a 12% drop in insulin and an 8% increase in insulin sensitivity. These results were seen in both genders.

“The publication of these new human data is fundamental in both clearly documenting the efficacy of InSea2 and the innovation it brings to consumers looking to improve blood sugar and insulin control post meal,” states Scott Steil, president of Nutra Bridge, Shoreview, MN. “The fact that it has been accepted for publication by a leading journal adds further credibility to the data since it has been peer reviewed. Finally, it offers solid value to our clients that use InSea2 in their product offering as they can now reference a published study.”

Published in WholeFoods Magazine, November 2011